AI drug discovery - Edgentiq

TandemAI Secures $22 Million Series A Extension to Advance AI-Powered Drug Discovery Platform

BullFrog AI to Showcase bfPREP at 2025 AI Drug Discovery & Development Summit

Recursion Pharmaceuticals and NVIDIA Forge $50 Million Alliance to Advance AI-Driven Drug Discovery

AI in Drug Discovery and Development Market Poised for Significant Growth, Projected to Reach US$34.05 Billion by 2033

Insilico Medicine’s AI Engine Accelerates GLP1R Peptide Design for Diabetes Treatment in Record Time

spot_img

Recently Added

Islamabad to Host Global Pharma Summit Addressing Exports, AI in Drug Discovery, and Quality Standards

Read more

AI Drug Discovery’s Slow Pace: Biological Complexity and Data Challenges Beyond Technological Hurdles

Read more

Almirall and Absci Broaden AI-Powered Dermatological Drug Discovery Alliance

Read more

Almirall and Absci Broaden AI-Powered Drug Discovery Partnership with New Dermatology Target

Read more

AuroBind: A Scalable AI Platform for Discovering Potent Drug Candidates

Read more

Elix and LINC Unveil World’s First Commercial Federated AI Platform for Drug Discovery

Read more

Gen AI News and Updates

spot_img

- Advertisement -

TandemAI Secures $22 Million Series A Extension to Advance AI-Powered Drug Discovery Platform

November 14, 2025

BullFrog AI to Showcase bfPREP at 2025 AI Drug Discovery & Development Summit

November 13, 2025

Recursion Pharmaceuticals and NVIDIA Forge $50 Million Alliance to Advance AI-Driven Drug Discovery

November 8, 2025